GGrantIndex
← Search

Shared Resource: Genomics

$459,814P30FY2019CANIH

Fred Hutchinson Cancer Research Center, Seattle WA

Investigators

Linked publications, trials & patents

Trial NCT06995898Trial NCT06682039Trial NCT06484595Trial NCT06193070Trial NCT05947500Trial NCT05930496Trial NCT05183828Trial NCT04902144Trial NCT04751383Trial NCT04682301Trial NCT04667481Trial NCT04660331Trial NCT04539366Trial NCT04505553Trial NCT04502524Trial NCT04500548Trial NCT04496219Trial NCT04489719Trial NCT04472338Trial NCT04466475Trial NCT04447313Trial NCT04444232Trial NCT04442581Trial NCT04431479Trial NCT04410900Trial NCT04387227Trial NCT04384692Trial NCT04383743Trial NCT04375631Trial NCT04372927Trial NCT04370301Trial NCT04359784Trial NCT04336943Trial NCT04329065Trial NCT04282187Trial NCT04260776Trial NCT04257578Trial NCT04254133Trial NCT04231877Trial NCT04220229Trial NCT04211766Trial NCT04208724Trial NCT04205409Trial NCT04200482Trial NCT04198922Trial NCT04196010Trial NCT04195945Trial NCT04195633Trial NCT04194918Trial NCT04188912Trial NCT04175431Trial NCT04156828Trial NCT04155840Trial NCT04151940Trial NCT04120246Trial NCT04111497Trial NCT04083183Trial NCT04083170Trial NCT04081779Trial NCT04081298Trial NCT04062955Trial NCT04060849Trial NCT03999515Trial NCT03991884Trial NCT03986502Trial NCT03980769Trial NCT03970096Trial NCT03907527Trial NCT03891784Trial NCT03864419Trial NCT03807063Trial NCT03806192Trial NCT03781778Trial NCT03779867Trial NCT03779854Trial NCT03778021Trial NCT03776864Trial NCT03749460Trial NCT03747484Trial NCT03737955Trial NCT03723863Trial NCT03718338Trial NCT03672981Trial NCT03670966Trial NCT03670069Trial NCT03660930Trial NCT03649841Trial NCT03641287Trial NCT03606486Trial NCT03602898Trial NCT03600038Trial NCT03585231Trial NCT03574012Trial NCT03570476Trial NCT03531918Trial NCT03525106Trial NCT03523195Trial NCT03522584Trial NCT03518242Trial NCT03516812

Abstract

Genomics Shared Resource Project Summary/Abstract The GSR is an expansion of the highly successful Fred Hutchinson Cancer Research Center (FHCRC) DNA (deoxyribonucleic acid) Array Laboratory launched in 1998, which was one of the first microarray core laboratories in the country. Initially, the resource was instrumental in assisting researchers in the development of a number of novel microarray applications, including assays examining protein-DNA interactions, DNA methylation profiling, and DNA replication timing patterns. The resource then transitioned from primarily making custom spotted arrays to using several commercial array-based platforms. The DNA Array Lab was later incorporated into a new entity - the Consortium Genomics Shared Resource - along with a newly developed second laboratory, the Genetic Analysis Lab, which was developed to provide capillary-based sequencing services (and years later also provide NextGen sequencing services). This expansion also required an expansion of support infrastructure and instrumentation for the main service areas. A major component of this infrastructure is HutchBASE, an in-house developed Laboratory Information and Management System (LIMS) system that supports online ordering of services, sample tracking, data management and analysis, and billing. The resource provides the highest quality services and expertise to aid the genomics-based needs of Cancer Consortium members through its two laboratories. The Genetic Analysis Laboratory provides: ? Capillary-based and NextGen sequencing technologies; ? Genotyping; and ? Quantitative (real-time) polymerase chain reaction (qPCR) services. The deoxyribonucleic acid (DNA) Array Laboratory provides Consortium members with end-to-end solutions for array-based experimentation, including: ? Consultation on technology selection; ? Assistance with experimental design; ? Assessment of RNA and DNA quality; ? Troubleshooting support; and ? Assistance with reviewing data quality and implementation of data analysis strategies.

View original record on NIH RePORTER →